Skip to content

Early Abdominal Wall Prosthesis Infections: Epidemiology, Risk Factors and Factors Linked to Recovery

Early Abdominal Wall Prosthesis Infections: Epidemiology, Risk Factors and Factors Linked to Recovery

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06498245
Acronym
AWPI
Enrollment
500
Registered
2024-07-12
Start date
2023-10-16
Completion date
2024-10-16
Last updated
2025-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Wall Prosthesis Infections

Keywords

Abdominal wall prosthesis, Antibiotic therapy, Surgical revision, Abdominal wall

Brief summary

Abdominal wall prosthesis infections are among the complications most feared by digestive surgeons. Indeed, this complication is associated with high morbidity and is difficult to manage (antibiotic therapy? surgical revision?). Much data is missing in the literature because there are many types of prosthesis, implemented in patients with very varied conditions and the treatment is not strictly speaking codified. The investigators wish to carry out a retrospective study on approximately 500 patients and research the main characteristics of the different infections (which microorganism? which site? what time of appearance), the factors linked to the appearance of these infections and above all how to optimize their management. charge.

Interventions

None listed

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Major subject (≥18 years old) * Subject operated on at the HUS in the department of Pr. Rohr between January 1, 2017 and July 26, 2023 * Operation of an incisional hernia cure with installation of an abdominal wall prosthesis * Absence of written opposition in the subject's medical file to the reuse of their data for scientific research purposes.

Exclusion criteria

* Subject having expressed his opposition to the reuse of his data for scientific research purposes.

Design outcomes

Primary

MeasureTime frame
Recovery of wall prosthesis infection after 3 months from the start of the infection3 months from the start of the infection of the prothesis

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026